Dmitry Kostyushev

1.4k total citations
64 papers, 943 citations indexed

About

Dmitry Kostyushev is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Dmitry Kostyushev has authored 64 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 23 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Dmitry Kostyushev's work include CRISPR and Genetic Engineering (19 papers), Hepatitis B Virus Studies (18 papers) and RNA Interference and Gene Delivery (14 papers). Dmitry Kostyushev is often cited by papers focused on CRISPR and Genetic Engineering (19 papers), Hepatitis B Virus Studies (18 papers) and RNA Interference and Gene Delivery (14 papers). Dmitry Kostyushev collaborates with scholars based in Russia, United Kingdom and Germany. Dmitry Kostyushev's co-authors include Vladimir Chulanov, Sergey Brezgin, Anastasiya Kostyusheva, Dieter Glebe, Andrey A. Zamyatnin, Alessandro Parodi, E. V Volchkova, Irina Goptar, Yu.Yu. Babin and Alexander N. Lukashev and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Dmitry Kostyushev

58 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitry Kostyushev Russia 16 632 203 130 104 101 64 943
Anastasiya Kostyusheva Russia 15 575 0.9× 178 0.9× 84 0.6× 91 0.9× 84 0.8× 43 759
Sergey Brezgin Russia 15 573 0.9× 188 0.9× 81 0.6× 89 0.9× 91 0.9× 44 759
Omid Gholizadeh Iran 17 325 0.5× 110 0.5× 83 0.6× 109 1.0× 48 0.5× 31 808
Darong Yang China 21 475 0.8× 162 0.8× 184 1.4× 143 1.4× 163 1.6× 36 1.1k
Shilin Li China 18 383 0.6× 180 0.9× 103 0.8× 134 1.3× 100 1.0× 63 957
Masaharu Somiya Japan 16 571 0.9× 111 0.5× 138 1.1× 209 2.0× 46 0.5× 34 846
Guigao Lin China 17 688 1.1× 177 0.9× 61 0.5× 320 3.1× 45 0.4× 71 1.2k
Xiaojun Hu China 18 264 0.4× 166 0.8× 58 0.4× 115 1.1× 170 1.7× 65 1.2k
Arash Arashkia Iran 19 405 0.6× 122 0.6× 112 0.9× 50 0.5× 81 0.8× 81 944
Yao Sun China 14 298 0.5× 129 0.6× 54 0.4× 27 0.3× 89 0.9× 23 814

Countries citing papers authored by Dmitry Kostyushev

Since Specialization
Citations

This map shows the geographic impact of Dmitry Kostyushev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry Kostyushev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry Kostyushev more than expected).

Fields of papers citing papers by Dmitry Kostyushev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitry Kostyushev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry Kostyushev. The network helps show where Dmitry Kostyushev may publish in the future.

Co-authorship network of co-authors of Dmitry Kostyushev

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitry Kostyushev. A scholar is included among the top collaborators of Dmitry Kostyushev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitry Kostyushev. Dmitry Kostyushev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kostyushev, Dmitry, et al.. (2025). CRISPR/Cas bioimaging: From whole body biodistribution to single-cell dynamics. Advanced Drug Delivery Reviews. 224. 115619–115619. 2 indexed citations
2.
Brezgin, Sergey, Anastasiya Kostyusheva, Vladimir Chulanov, et al.. (2025). Overcoming Antibiotic Resistance and Treating Bacterial Infections with Biological Nanoparticles. International Journal of Molecular Sciences. 26(24). 11780–11780.
3.
Brezgin, Sergey, et al.. (2025). The m6A methylation system limits hepatitis B virus replication. Biomeditsinskaya Khimiya. 71(2). 127–136.
4.
Brezgin, Sergey, Irina Goptar, Vladimir Chulanov, et al.. (2025). The Role of m6A-RNA Methylation in the Development, Progression, and Treatment Response of Bladder Cancer. Biochemistry (Moscow). 90(6). 650–670. 1 indexed citations
5.
Brezgin, Sergey, Anastasiya Kostyusheva, Н.В. Пономарева, et al.. (2024). Basic Guide for Approaching Drug Delivery with Extracellular Vesicles. International Journal of Molecular Sciences. 25(19). 10401–10401. 12 indexed citations
6.
Kostyusheva, Anastasiya, Sergey Brezgin, Н.В. Пономарева, et al.. (2024). Clinical and Translational Landscape of Viral Gene Therapies. Cells. 13(22). 1916–1916. 5 indexed citations
7.
Kostyushev, Dmitry, et al.. (2024). Hybrid plasmonic nanodiamonds for thermometry and local photothermal therapy of melanoma: a comparative study. Nanophotonics. 13(22). 4111–4125. 2 indexed citations
8.
Brezgin, Sergey, Anastasiya Kostyusheva, Ekaterina Bayurova, et al.. (2023). Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics. Pharmaceutics. 15(2). 534–534. 9 indexed citations
9.
Kostyushev, Dmitry, et al.. (2022). Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer. World Journal of Gastroenterology. 28(33). 4812–4822. 5 indexed citations
10.
Kostyushev, Dmitry, et al.. (2021). CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical Barriers. Nucleic Acid Therapeutics. 32(1). 14–28. 4 indexed citations
11.
Kostyushev, Dmitry, et al.. (2021). May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases?. Advances in Therapy. 39(1). 430–440. 7 indexed citations
12.
Kostyusheva, Anastasiya, Sergey Brezgin, Dieter Glebe, Dmitry Kostyushev, & Vladimir Chulanov. (2021). Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification. Emerging Microbes & Infections. 10(1). 2264–2275. 65 indexed citations
13.
Borodina, Tatiana, Dmitry Kostyushev, Andrey A. Zamyatnin, & Alessandro Parodi. (2021). Nanomedicine for Treating Diabetic Retinopathy Vascular Degeneration. SHILAP Revista de lepidopterología. 1(3). 306–322. 10 indexed citations
14.
Wang, Xiaoyin, Ronak Derakhshandeh, Dmitry Kostyushev, et al.. (2020). Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials. PLoS ONE. 15(8). e0237401–e0237401. 2 indexed citations
15.
16.
Kostyushev, Dmitry, et al.. (2019). Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9. Scientific Reports. 9(1). 1847–1847. 46 indexed citations
17.
Kostyushev, Dmitry, et al.. (2019). Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus. Cellular and Molecular Life Sciences. 76(9). 1779–1794. 63 indexed citations
18.
Kostyushev, Dmitry, et al.. (2018). INCREASED FORMATION OF PHOSPHORYLATED H2AX FOCI IN NUCLEI OF CELLS INFECTED BY HEPATITIS B AND B+D VIRUSES. Problems of Virology. 63(4). 165–170. 2 indexed citations
19.
Chulanov, Vladimir, et al.. (2017). Modern View on the Problem of Choosing a Vaccine against Hepatitis B. Epidemiology and Vaccinal Prevention. 16(4). 65–72. 6 indexed citations
20.
Kostyushev, Dmitry, Sergey Brezgin, Dieter Glebe, et al.. (2017). Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B. Terapevticheskii arkhiv. 89(11). 21–26. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasiya Kostyusheva Breakdown of academic impact, for papers by Sergey Brezgin Breakdown of academic impact, for papers by Omid Gholizadeh Breakdown of academic impact, for papers by Darong Yang Breakdown of academic impact, for papers by Shilin Li Breakdown of academic impact, for papers by Masaharu Somiya Breakdown of academic impact, for papers by Guigao Lin Breakdown of academic impact, for papers by Xiaojun Hu Breakdown of academic impact, for papers by Arash Arashkia Breakdown of academic impact, for papers by Yao Sun
Rankless by CCL
2026